Genitourinary Radiology: Page 5

Monrol to supply Telix with Lu-177 for renal cancer trial

By AuntMinnieEurope.com staff writers

Eczacıbaşı-Monrol Nuclear Products will provide lutetium-177 (Lu-177) to Telix Pharmaceuticals Limited for a phase II clinical trial of its Starlite 2 renal cancer therapy medication TLX250.

May 10, 2022

MRI radiomics help predict prostate cancer metastases

By Kate Madden Yee

Radiomics features extracted from multiparametric MRI exams can help predict whether prostate cancer will metastasize, according to research presented at the International Society for Magnetic Resonance in Medicine meeting in London, U.K.

May 10, 2022

Quibim signs Human Bytes as distributor

By AuntMinnieEurope.com staff writers

Artificial intelligence (AI) software developer Quibim has named Human Bytes as its distributor for the Nordic countries.

April 4, 2022

ESR survey shows major awareness gap on female pelvic MRI

By Philip Ward

Less than half of radiologists use guidelines from the European Society of Urogenital Radiology on female pelvic MRI, highlighting the need for an awareness campaign, a survey of European Society of Radiology (ESR) members has found.

March 29, 2022

BJR publishes special focus on prostate cancer

By AuntMinnieEurope.com staff writers

The British Journal of Radiology (BJR) has dedicated its latest issue to a diverse collection of prostate cancer articles.

March 15, 2022

ECR: How can imaging screen for COVID damage to kidneys?

By Kate Madden Yee

With the COVID-19 pandemic now in at least a fourth wave, physicians have a better understanding of how the disease affects the body beyond the lungs -- including the kidneys. Experts shared their knowledge and experiences on 2 March at the ECR 2022 Overture.

March 2, 2022

MRI makes sustained clinical progress in female urethra

By Edna Astbury-Ward, PhD

MRI can supply vital information about the anatomy and pathology of the female urethra, and it can guide clinical management and provide a road map for surgical procedures, according to new analysis by European genitourinary radiologists.

January 19, 2022

U.K. researchers get cash injection for MRI prostate cancer trial

By AuntMinnieEurope.com staff writers

A team from Imperial College London and Imperial College Healthcare NHS Trust has been awarded 1 million pounds (1.2 million euros) to conduct a trial to determine whether a new MRI method can diagnose prostate cancer.

January 19, 2022

When to biopsy: How prostate MRI can transform best practice

By Philip Ward

In the era of MRI targeting, do all prostate cancer patients require an additional 12-core systematic biopsy? Moving away from default systematic biopsy in some cases may be wise, according to German researcher Dr. Dominik Deniffel, who has won a prestigious award for trainees at RSNA 2021.

December 1, 2021

CLS begins evaluation of new thermal therapy system

By AuntMinnieEurope.com staff writers

Image-guided focal laser ablation technology developer Clinical Laserthermia Systems (CLS) said that its new Transberg thermal therapy system is now being evaluated for use in MRI/ultrasound fusion-guided focal laser ablation of prostate tumors.

October 26, 2021

Lucida launches validation study for AI software

By AuntMinnieEurope.com staff writers

Researchers from U.K. artificial intelligence (AI) software developer Lucida Medical and Hampshire Hospitals NHS Foundation Trust have launched a retrospective cohort validation study of the firm's Pi AI-based software for prostate cancer detection on MRI.

September 6, 2021

Can AI help to improve radiologist accuracy in prostate MRI?

By Erik L. Ridley

An artificial intelligence (AI)-based computer-aided detection software application can improve the performance of radiologists in reading biparametric prostate MRI exams, according to Swiss-led research.

August 31, 2021

Previous Page

Page 5 of 22

Next Page